Haven't used Personalis, inc. yet?
Ask Trustburn

Ask Trustburn about Personalis, inc.

Based on 11 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Questions & Answers

No questions yet โ€” be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website โ€” its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="personalis-inc" data-lang="en"></div>
More widgets

About Personalis, inc.

Personalis, Inc. is a cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patientโ€™s cancer and immune response. The companyโ€™s NeXT Platform is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample.

Personalis, Inc. is a leading cancer genomics company that is revolutionizing the development of next-generation therapies by providing more comprehensive molecular data about each patient's cancer and immune response. The company's NeXT Platform is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample.

The NeXT Platform uses advanced sequencing technologies and bioinformatics algorithms to analyze DNA and RNA from tumor samples. This allows Personalis to provide highly accurate genomic data that can be used by biopharmaceutical companies to develop targeted therapies for individual patients.

One of the key advantages of Personalis' approach is its ability to provide comprehensive genomic profiling in a single test. This means that biopharmaceutical companies can get a complete picture of each patient's cancer and immune response without having to perform multiple tests or wait for results from different labs.

In addition to its core genomic profiling services, Personalis also offers a range of other solutions designed to support drug development programs. These include custom assay development services, clinical trial support services, and bioinformatics consulting services.

Personalis has established itself as a leader in the field of cancer genomics thanks in large part to its team of world-class scientists and engineers. The company's staff includes experts in genetics, bioinformatics, oncology research, software engineering, and more.

Another key factor contributing to Personalis' success is its commitment to innovation. The company invests heavily in research and development activities aimed at improving its technology platform and expanding its service offerings.

Overall, Personalis represents an exciting opportunity for biopharmaceutical companies looking for innovative solutions for developing next-generation cancer therapies. With its cutting-edge technology platform and world-class team of experts, this company is well-positioned for continued growth and success in the years ahead.

Address
1330 o brien drive
Categories
Biotechnology